Photodynamic therapy with verteporfin vs photodynamic therapy with 5% dextrose
Gain of 3 or more lines of visual acuity · people with neovascular age‐related macular degeneration
Photodynamic therapy with verteporfin leads to higher gain of 3 or more lines (15 or more letters) compared with photodynamic therapy with 5% dextrose (high certainty).
1 finding from 1 review
- Photodynamic therapy for neovascular age‐related macular degeneration 2007 · Cochrane Headline outcomes onlyRR 2.23 [1.19, 4.19]3 studies · 941 participantsHigh